Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Cell Research|January 21, 2021
Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavagesEls Wauters, Pierre Van Mol, Abhishek Dinkarnath Garg, et al.Frontiers in Immunology|October 24, 2022
Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregatesBert Malengier-Devlies, Jessica Filtjens, Kourosh Ahmadzadeh, et al.Clinical Chemistry|June 30, 2022
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing DatasetsHuiwen Che, Tatjana Jatsenko, Liesbeth Lenaerts, et al.American Journal of Respiratory Cell and Molecular Biology|October 10, 2025
Macrophage CCL18 Promotes Lung Inflammation in Checkpoint Inhibitor PneumonitisMohammad I Ghanbar, Andres Villabona-Rueda, Nicolas Philip, et al.Ebiomedicine|August 8, 2022
Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19Caroline P Martens, Pierre Van Mol, Joost Wauters, et al.Frontiers in Immunology|March 20, 2026
PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patientsSeverine Planel, Guillaume Vayssière, Gianni Maggipinto, et al.Nature|May 3, 2019
Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cellsJiyeon Kim, Zeping Hu, Ling Cai, et al.Oncoimmunology|June 7, 2023
Trial watch: chemotherapy-induced immunogenic cell death in oncologyJenny Sprooten, Raquel S Laureano, Isaure Vanmeerbeek, et al.Nature|May 25, 2017
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cellsJiyeon Kim, Zeping Hu, Ling Cai, et al.Thorax|June 23, 2017
Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohortsPeter J Castaldi, Marta Benet, Hans Petersen, et al.Pageof 7